News & Perspective

Aug 31, 2018

Aug 31, 2018

ASP Scan (Weekly) for Aug 31, 2018

C diff testing in the NICU
Resistant gonorrhea in Europe
ESBL bacteria in sprouts
Antibiotic resistance risk factors
Business case for stewardship
UK FMT C diff guidelines
Pharmacist-led stewardship
Typhoid vaccine as stewardship tool
Web training for antibiotic stewardship
Chest x-ray and pneumonia
New antibiotic for intra-abdominal infections
Bedaquiline for MDR-TB
Australian stewardship study

Nov 06, 2015

Nov 06, 2015
Flu shot

US flu levels still low, with few global hot spots

More states are reporting their first cases and even deaths, but at the national level, flu levels remained low last week. 

Nov 18, 2011

Nov 18, 2011

WHO: Southern Hemisphere wraps up its flu season

(CIDRAP News) – Influenza activity in the Southern Hemisphere has mostly returned to off-season levels, with only a few countries in tropical regions reporting significant activity, the World Health Organization (WHO) reported today.

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Oct 28, 2010

Oct 28, 2010

CDC sees smooth road so far for flu vaccine

(CIDRAP News) – In a flu vaccine update at a federal advisory meeting today, officials with the US Centers for Disease Control and Prevention (CDC) said early signs suggest flu vaccine uptake in children is on par with last year and that enhanced monitoring for narcolepsy and seizures has turned up no signals of trouble.

Oct 13, 2010

Oct 13, 2010

H3N2 a player in early Northern Hemisphere flu season

(CIDRAP News) – More signals suggest the Southern Hemisphere's flu season is winding down, while activity is low at the start of the Northern Hemisphere's flu season, except in China, which is seeing moderate H3N2 circulation.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»